Trials / Completed
CompletedNCT02813967
S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Patients With Esophageal Cancer
S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Chinese Patients With Squamous Cell Carcinoma of Esophagus: A Prospective, Randomized, Multi-center Phase-III Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 298 (actual)
- Sponsor
- Zhejiang Cancer Hospital · Academic / Other
- Sex
- All
- Age
- 70 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This was a randomised, multicenter, phase 3 trial. Patients who were age of 70 years or older with histologically confirmed esophageal cancer were randomly assigned to S-1 concurrent with radiotherapy or radiotherapy alone.The primary endpoint was overall survival.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Radiotherapy 54 Gy | Radiotherapy was administered in 1.8 Gy fractions 5 times weekly to a total dose of 54 Gy. |
| RADIATION | Radiotherapy 60 Gy | Radiotherapy was administered in 2 Gy fractions 5 times weekly to a total dose of 60Gy. |
| DRUG | S-1 | S-1 70mg/m2 was administered on days 1-14 and 29-42. |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2020-08-01
- Completion
- 2020-08-01
- First posted
- 2016-06-27
- Last updated
- 2020-09-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02813967. Inclusion in this directory is not an endorsement.